Key research presented at ASH 2010
21 Feb 2011
Key research presented at ASH 2010
The role of comorbidity indices in the prognosis of elderly MDS patients
Burkitt’s lymphoma in the elderly
Changing the paradigm in frontline CML therapy
ENESTnd trial comparing nilotinib and imatinib as first line CML therapy
Haematological cancers in the elderly
The importance of myelodysplastic syndrome diagnosis
Key lymphoma research from ASH 2010
The DASISION chronic myeloid leukaemia trial
CLL related research from ASH 2010
Key multiple myeloma research from ASH 2010
The role of plasma cell biology in multiple myeloma